Fig. 11

Kaplan–Meier analysis of lung adenocarcinoma-specific overall survival of 673 patients with tumors expressing different levels of a CTD-2510F5.4 and b CTB-193M12.5
Kaplan–Meier analysis of lung adenocarcinoma-specific overall survival of 673 patients with tumors expressing different levels of a CTD-2510F5.4 and b CTB-193M12.5